ABSTRACT P2-Glycoprotein I (f32-GPI), a phospholipidbinding plasma protein, is an absolute requirement (cofactor) for the binding of autoimmune-type anti-cardiolipin (aCL) antibodies to cardiolipin (CL). The nature of this cofactor activity and the specific regions of the molecule involved have not yet been determined. We have identified a preparation of P2-GPI that lacks aCL antibody cofactor activity. Analysis of the structural differences between the active and inactive forms enabled identification of the region of 32-GPI critically important for aCL cofactor activity. The active form of P2-GPI bound CL and displayed cofactor activity down to 1 ,ug/ml. The inactive form failed to bind CL and possessed no cofactor activity even at concentrations up to 94 ,ug/ml, indicating that the ability of P2-GPI to bind lipid is an absolute requirement for aCL cofactor activity. Both forms possessed identical N-terminal sequences and were recognized as essentially immunoreactively identical by polyclonal antisera to 2-GPI.
Anti-cardiolipin (aCL) antibodies are autoantibodies detected in a wide range of conditions including infections (1) and autoimmune disorders (2) . However, severe clinical complications such as thrombosis (2) and recurrent spontaneous fetal loss (3) are only reported in the autoimmune group of patients, including those with the primary antiphospholipid syndrome (4) . Furthermore, 82-glycoprotein I (f32-GPI) plays a critical role (as cofactor) in the recognition of the phospholipid antigen cardiolipin (CL) by aCL antibodies purified from patients with autoimmune disease (5) but not from patients with infection (6) . This suggests that the interaction of the autoimmune type of aCL antibodies with j32-GPI may be associated with the reported thrombotic complications seen in some patients with aCL antibodies.
/82-GPI was first reported by Shultze et al. (7) , and the complete amino acid sequence was published by Lozier et al. (8) . It is a single-chain polypeptide (326 amino acids) with an apparent molecular mass of -50 kDa, contains a high proportion of proline and cysteine residues, and is highly glycosylated (8) . A number of isoforms have been reported (9) . Although its physiological role remains unclear, P2-GPI is known to be associated with lipoprotein structures, especially chylomicrons (10) , and to bind platelets (11) , heparin
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p2-GPI is a member of the short consensus repeat or complement control protein repeat superfamily (19) . These proteins have in common a repeating motif of -60 amino acids, with a highly conserved pattern of cysteine residues.
P32-GPI is composed of five of these repeats (20) .
The structural characteristics of 32-GPI required for aCL antibody cofactor activity, to our knowledge, have not been elucidated. This information may help in identifying the chemical domains that are critical for the interaction(s) among 82-GPI, phospholipid, and aCL antibody. The identification of a form of P2-GPI that lacked cofactor activity enabled us to further characterize the interaction(s). Therefore, the aim of this study was to investigate the functional and structural differences between the active and inactive forms of (2-GPI and to identify the specific regions of this molecule important for binding lipid and for aCL cofactor activity.
METHODS
Purifi'cation of %-GPI. P2-GPI was purified from normal human serum as described (5) . Briefly, human serum was subjected to phospholipid affinity chromatography (21), followed by gel-filtration (Pharmacia Superose 12/30 column) and ion-exchange chromatography (Pharmacia Mono S HR 5/5 column). Fractions containing j2-GPI were checked for purity by SDS/PAGE. P2-GPI prepared using this method in our laboratory will be referred to as P2-GPIL".
A preparation of f32-GPI that was previously commercially 21) followed by ion-exchange chromatography on a Pharmacia Mono S HR 5/5 column as described (6) .
In the first series of experiments, the cofactor activity of I32-GPILAB (0-9.1 p.g/ml) and I32-GPIcoM (0-94 yg/ml) was determined when incubated with a constant concentration of purified aCL (1 ,ug The fractions generated were tested for the presence of cofactor activity (at a 1:5 dilution with aCL at 1 jig/ml) by using the modified aCL ELISA described above.
Binding of 125I-Labeled P2-GPILAB and 125I-Labeled l2-GPICoM to CL and Phosphatidylcholine (PC). 832-GPILAB (1.6
,ug) and f32-GPIcoM (1.6 jig) were radiolabeled with 1251 using the lactoperoxidase method as described (22) . For min, and then washed three times with PBS. Radioactivity in individual wells was then measured in a y counter.
RIA for P2-GPI. P2-GPI levels in fractions from the chromatofocusing experiments were measured using a competitive RIA as described (6) . Fractions were tested at dilutions of 1:50 and 1:100, 1:100 and 1:200, 1:400 and 1:800, or 1:800 and 1:1600, depending on their protein concentration estimated from the absorbance at 280 nm (A280).
This RIA system was also used to examine the antigenic similarity between I32-GPILAB and ,82-GPICoM. Four standard curves were constructed with 125I-labeled P2-GPILAB as the labeled species and serial dilutions (1750 ng-27.3 ng) of I32-GPILAB (curve 1) or P2-GPIcoM (curve 2) as the competitor species or with 125I-labeled P2-GPIcoM as the labeled species and I32-GPILAB (curve 3) or 3r-GPICOM (curve 4) as the unlabeled species. The standard curves were constructed using a 4-parameter logistic curve-fitting program (23) .
Immunodiffusion. This was performed on glass plates using 1% agarose and PBS by the method of Ouchterlony (24) .
Amino Acid Sequence Analysis. 32-GPILAB (50 jig) and t2-GPIcoM (50 ,ug) were subjected to automated Edman degradation using an Applied Biosystems sequencer (model 477A) and an on-line phenylthiohydantoin amino acid derivative analyzer (model 120A) as described (5) . Fig. 2A) . In a further series ofexperiments, we were unable to demonstrate cofactor activity even at A2-GPIcOM concentrations of 256 ,ug/ml (data not shown).
aCL binding activity increased with increasing concentration of aCL only in the presence of 832-GPILAB (Fig. 2B ).
There was no significant binding demonstrated with buffer or f32-GPIcoM.
Chromatofocusing. Chromatofocusing revealed that a number of different isoelectric subspecies were present in the two samples. I2-GPIcoM contained three major peaks (apparent pl values, 6.7, 6.6, and 6.3) and four minor peaks (pI values, 6.9, 6.8, 6.5, and 5.8). Most of the material eluted between fractions 20 and 32 with one peak eluting at fraction 40.
P32-GPILAB, as well as containing material that eluted after fraction 20 (pI values 6.9, 6.8, 6.7, 6.6, 6.4, and 6.0), contained three isoelectric species that eluted in fractions Fig. 3 . aCL cofactor activity was demonstrated for all isoelectric species of P2-GPILAB (Fig.   3A) . The level of cofactor activity was proportional to the concentration of p2-GPI in the fractions as detected by RIA (r = 0.89; P < 0.001). No cofactor activity above background was detected in any of the eluted fractions from I32-GPIcoM (Fig. 3B) .
Binding of 12sI-Labeled 32-GPILAB and '2sI-Labeled P2-GPICoM to CL and PC. 1251-labeled P2-GPILAB was able to bind to wells coated with negatively charged phospholipid (CL)-coated wells but not to PC-coated wells (Fig. 4) . In contrast, 125I-labeled P2-GPIcoM showed no significant binding to CL-or PC-coated wells. In a further set of experiments RIA Experiments. The four standard curves generated for the RIA were of identical slope (Fig. 5) and consistent with the standard curve of the competitive RIA for P32-GPI (6) .
When using 125I-labeled P2-GPILAB, 50%o B/Bo was 270.8 ng/ml for P2-GPILAB and 236.8 ng/ml for f2-GPICoM. Similarly, with 1251-labeled 832-GPIcoM, 50% B/Bo was 260.2 ng/ml for 82-GPIL" and 232.6 ng/ml for f3r-GPICM.
Immunodiffusion. Rabbit anti-j2-GPI antibody recognizes both forms of (2-GPI, and a lack of spurs indicated total immunoreactive identity (data not shown).
Amino Acid Analysis. 32-GPILAB and p2-GPIcoM were found to have an identical amino acid composition (data not shown) consistent with that published for P2-GPI (8, 20) . N-terminal sequencing revealed a single sequence for P2-GPILAB. However, each cycle of the Edman degradation revealed three phenylthiohydantoin amino acid derivatives for P2-GPICOM, the relative proportions of each indicating the presence of two major sequences and one minor ( Table 1 ).
The result is consistent with P2-GPIcoM existing predominantly as a molecule cleaved between Lys-317 and Thr-318 (domain 5) and the cleaved segment remaining attached to the parent molecule by disulfide bonding (Fig. 6) . A smaller proportion of the preparation exists as a similar structure but is cleaved between Ala-314 and Phe-315. This resulted in Table 1 . N-terminal sequencing of 32-GPICoM 32-GPIL"
,2-GPICOM i) major One of the previously reported characteristics of P32-GPI is its ability to bind negatively charged phospholipids (13) , and this is likely to be critical to its role as aCL antibody cofactor. The precise regions of132-GPI involved in its interaction with negatively charged phospholipids and with other structures, to our knowledge, have not previously been determined.
Prior to the publication of the amino acid sequence of P2-GPI, Schousboe (25) suggested that the lipid-binding activity of P2-GPI was due to a hydrophilic interaction between a histidine-rich region of the molecule and the negatively charged phospholipids. However, the published sequence (20) reveals that A2-GPI has only five histidine residues; two in the fifth domain, one in the fourth domain, and two in the third domain. Wurm (13) proposed that ionic and hydrophobic interactions were important in the binding of lipids by P2-GPI but did not indicate a specific binding site. Recently, it has been suggested that a sequence of highly positively charged amino acids, Lys-Asn-Lys-Glu-Lys-Lys (residues 281-288), predicted to be a surface-exposed turn, is a likely lipid-binding site (20) . However, our results suggest that lipid binding is dependent on the integrity of the region that includes Lys-317 and Thr-318. This region is probably surface-exposed as it was susceptible to enzymatic cleavage (clipped), and the resulting disruption to this sequence resulted in complete loss of lipid-binding activity. Interestingly, the C-terminal clip is in the vicinity of a histidine residue (His-310).
Lozier et al. (8) mapped only 6 ofthe 11 disulfide bonds for human P2-GPI, and only one of these, Cys-281 to Cys-288, was in the fifth domain. In contrast, Kato and Enjyoji (26) have determined all disulfide bonds for bovine P2-GPI, and the linkages in the fifth domain are Cys-245 to Cys-296, Cys-281 to Cys-306, and Cys-288 to Cys-326. This model results in a more conserved disulfide bond pattern for the fifth domain (i.e., similar to domains 1 to 4). If these assignments are used for human f32-GPI, then the sequence disrupted by the clip would be linked by a disulfide bond to Cys-288, immediately adjacent to the highly positive charged sequence Lys-Asn-Lys-Glu-Lys-Lys, a possible lipid binding site (20) . Consequently, it is possible that a clip between residues Lys-317 and Thr-318 could result in a conformational change in this or other lipid-binding sites and alter the ability of P2-GPI to bind lipid. However, it is not yet known whether the clip causes such a conformational change.
The cause of the alteration to P2-GPIcoM is not known but is likely to be an artefact of the purification procedure. The major clip is a trypsin-like cleavage (i.e., C-terminal to lysine) and such a protease may have been copurified with X32-GPICOM or introduced as a contaminant. There are reports of this type of clipped molecule occurring naturally. For example, the membrane-fusing glycoproteins of most enveloped viruses exist as cleaved disulfide-linked complexes (27) .
Nevertheless, it is unlikely that P2-GPICoM is a naturally occurring form of the molecule, as it is doubtful that the purification technique employed could selectively purify only the clipped form of f2-GPI. However, it is interesting to note that sequence that includes Lys-317 and Thr-318 satisfies the criteria for a thrombin cleavage site as proposed by Chang (28) . It is possible that cleavage of 2-GPI by thrombin may operate as a regulatory mechanism to modify its biological activity.
The microheterogeneity of P32-GPI is well-established and a number of isoelectric subspecies have been reported (9) . There have been no reports as to whether all such forms possess aCL cofactor activity or bind lipid. If these activities of P2-GPI are due to simple charge interactions with negatively charged phospholipid, it may be hypothesized that the presence or extent of activity might be correlated with the charge of the subspecies. However, our results indicate that all isoelectric subspecies of the native molecule possessed significant cofactor activity. Despite having subspecies with pI values that are similar to the pI value of the active form, the clipped form of f32-GPI possessed no subspecies with any discernible cofactor activity. Our results indicate that the factors responsible for the isoelectric microheterogeneity of the (32-GPI molecule are not important determinants for aCL cofactor (and presumably lipid binding) activity.
These results have important implications for researchers investigating the properties and function of P2-GPI. It is evident that the clipped form of P2-GPI, previously commercially available, would be unsuitable for experiments de- signed to test whether native P2-GPI possesses aCL cofactor activity. Recently, there has been a report (29) by investigators who were unable to demonstrate any aCL cofactor activity by 2-GPI. A number of purification procedures exist for purifying P2-GPI (5, 30) and some of these may be more likely to produce /2-GPI with this or similar alterations. These negative findings may be due to the use of the clipped, and hence inactive, form of P32-GPI. We These results may also prove to be of benefit in the study of P2-GPI's anti-coagulant properties and its role in lipid metabolism.
